Non‐invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis
Prenatal Diagnosis2015Vol. 35(10), pp. 950–958
Citations Over TimeTop 10% of 2015 papers
Melissa Hill, Philip Twiss, Talitha I. Verhoef, Suzanne Drury, Fiona McKay, Sarah Mason, Lucy Jenkins, Stephen Morris, Lyn S. Chitty
Abstract
We have developed NIPD for risk stratification in around a third of CF families. There are economic implications due to potential increased test demand to inform postnatal management rather than to inform decisions around termination of an affected pregnancy.
Related Papers
- → Cell-free DNA testing: An aid to prenatal sonographic diagnosis(2014)7 cited
- → Systematic review of noninvasive prenatal diagnosis for abnormal chromosome genetic diseases using free fetal DNA in maternal plasma(2015)5 cited
- Comparison of traditional prenatal diagnosis procedures and Cell-Free DNA in maternal plasma as a new molecular approach for prenatal diagnosis(2018)
- Research Progress of Cell-free Fetal DNA in Prenatal Diagnosis of Aneuploidy(2010)
- → Appling cell-free fetal DNA and RNA of maternal plasma in non-invasive prenatal diagnosis(2013)